ALB and amyotrophic lateral sclerosis: While studies exploring the associations of clinical chemistry markers with outcome of patients with ALS are accumulating, prior studies have mainly focused on specific sets of biomarkers, such as lipids and lipoproteins [14, 15], creatinine and albumin [16, 17], and inflammatory markers [18].